Literature DB >> 8144198

Complement dependent cytotoxicity of sensory ganglion neurons mediated by the gp120 glycoprotein of HIV-1.

S Apostolski1, T McAlarney, A P Hays, N Latov.   

Abstract

Patients infected with HIV-1 frequently have a sensory neuropathy, but the cause is unknown. We found that the gp120 glycoprotein of HIV-1 bound to the surface of cultured rat dorsal root ganglia (DRG) neurons, and activated the complement cascade to lyse the neuronal cells. Cytotoxicity was measured by a 51Cr-release assay, and deposits of the C5b-9 complement complex were detected on the affected cells. As controls, gp120 or complement alone, or rgp120 plus deactivated complement, did not damage the neuronal cells, and fibroblasts were unaffected. The gp120 glycoprotein can thereby damage DRG neurons by complement dependent mechanisms. This interaction may contribute to the development of the sensory neuropathy in AIDS.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8144198     DOI: 10.3109/08820139409063432

Source DB:  PubMed          Journal:  Immunol Invest        ISSN: 0882-0139            Impact factor:   3.657


  11 in total

Review 1.  Schwann cells as a therapeutic target for peripheral neuropathies.

Authors:  Helmar C Lehmann; Ahmet Höke
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-12       Impact factor: 4.388

Review 2.  [HIV-associated neuropathies].

Authors:  K Hahn; I W Husstedt
Journal:  Nervenarzt       Date:  2010-04       Impact factor: 1.214

3.  Autonomic neuropathy in patients with HIV: course, impact of disease stage, and medication.

Authors:  T Glück; E Degenhardt; J Schölmerich; B Lang; J Grossmann; R H Straub
Journal:  Clin Auton Res       Date:  2000-02       Impact factor: 4.435

Review 4.  Mechanisms of distal axonal degeneration in peripheral neuropathies.

Authors:  Christopher R Cashman; Ahmet Höke
Journal:  Neurosci Lett       Date:  2015-01-21       Impact factor: 3.046

Review 5.  Neuropathy in Human Immunodeficiency Virus: A Review of the Underlying Pathogenesis and Treatment.

Authors:  Lakshya Motwani; Nailah Asif; Apurva Patel; Deepanjali Vedantam; Devyani S Poman
Journal:  Cureus       Date:  2022-06-13

Review 6.  [Epidemiology and therapy of pain and depression during HIV and AIDS].

Authors:  I W Husstedt; D Reichelt; F Kästner; S Evers; K Hahn
Journal:  Schmerz       Date:  2009-12       Impact factor: 1.107

7.  GPI-1046 protects dorsal root ganglia from gp120-induced axonal injury by modulating store-operated calcium entry.

Authors:  Ahmet Höke; Michael Morris; Norman J Haughey
Journal:  J Peripher Nerv Syst       Date:  2009-03       Impact factor: 3.494

8.  Antinociceptive effects of topical mepivacaine in a rat model of HIV-associated peripheral neuropathic pain.

Authors:  Jacqueline Sagen; Daniel A Castellanos; Aldric T Hama
Journal:  J Pain Res       Date:  2016-06-06       Impact factor: 3.133

Review 9.  HIV-related neuropathy: current perspectives.

Authors:  Sonja G Schütz; Jessica Robinson-Papp
Journal:  HIV AIDS (Auckl)       Date:  2013-09-11

Review 10.  Drug-Induced Peripheral Neuropathy: A Narrative Review.

Authors:  Mark R Jones; Ivan Urits; John Wolf; Devin Corrigan; Luc Colburn; Emily Peterson; Amber Williamson; Omar Viswanath
Journal:  Curr Clin Pharmacol       Date:  2020
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.